Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.
Wanbangde (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Group Co., Ltd. ("Wanbangde Pharmaceutical"), has been selected for the Alzheimer's disease project under the national major special project for innovative drug development led by the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The company has received the approval from the National Health Commission of China's Center for Biotechnology Development.
Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Holding Group Pharmaceutical Group Co., Ltd. ("Wanbangde Pharmaceutical Holding Group Pharmaceutical"), has been selected for the Alzheimer's disease project under the National Science and Technology Major Project for Innovative Drug Development led by the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The company has received approval from the National Health Commission's China Center for Biotechnology Development.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
